期刊文献+

腹腔免疫化疗预防胃癌术后腹腔复发的临床研究 被引量:17

Clinical study on the recurrence of peritoneal cavity with intraperitoneal chemo-immunotherapy after gastric cancer sugery.Hua Yawei,Zhang Jianzhe,Li Tian
原文传递
导出
摘要 目的评价腹腔免疫化疗对侵及浆膜的进行期胃癌根治术后预防腹腔复发的疗效。方法1992年10月至1994年12月对199例可切除的进行期胃癌病人随机分成治疗组和对照组。治疗组104例应用卡铂200mg+白介素Ⅱ20~40万单位加入生理盐水200~300ml进行多点腹腔穿刺注射,连用5周,4个月后重复。对照组95例则常规给予优福定口服。结果治疗组和对照组3年生存率分别为606%、453%(P<001)。腹腔复发率分别为48%、349%(P<001)。结论腹腔免疫化疗可预防侵犯浆膜的进展期胃癌术后腹腔复发,是一种方法简便,安全可行,副作用少。 Objective To evaluate the effect of preventing the recurrence of peritoneal cavity with intraperitoneal chemo-immunotherapy after resection of gastric cancer,which had penetrated the serosa and visceral peritoneum. Methods From October 1992 to December 1994,199 cases were devided into treatment group(group )and control group(group ).104 cases(group )were treated with intraperitoneal chemo-immunotherpy after resection of advance gastic cancer.200mg carboplatin and interleukin- (24)10\+5U in 200300ml 0\^9% sodium chloride were intraperitoneally injected every week for 5 times.After 4 months the aboro treatment were performed again.95 cases(group )as control were used to take tablets of UFT. Results The 3-year survival rate in group and group were 60\^6%,45\^3%(P<0\^01).The recurrence of peritoneal cavity in group and group were 4\^8%,34\^95%(P<0\^01). Conclusion This is a simple,safe,effective and repeated method with less adverse effect for preventing the recurrence of peritoneal cavity after resection of invaded theserosa from advanced gastric cancer.
出处 《中国实用外科杂志》 CSCD 北大核心 1999年第6期358-359,共2页 Chinese Journal of Practical Surgery
关键词 胃肿瘤 腹腔内注射 免疫疗法 复发 Chemo-immunotherapy\ Stomach neoplasms\ Injection intraperitoneal
  • 相关文献

参考文献7

二级参考文献3

  • 1徐光炜,胃癌,1987年,82页
  • 2程中,国外临床,1991年,5卷,160页
  • 3陈峻青,实用外科杂志,1991年,11卷,426页

共引文献135

同被引文献67

引证文献17

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部